These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 15481992)
1. Structure modifications of 6-aminoquinolones with potent anti-HIV activity. Tabarrini O; Stevens M; Cecchetti V; Sabatini S; Dell'Uomo M; Manfroni G; Palumbo M; Pannecouque C; De Clercq E; Fravolini A J Med Chem; 2004 Oct; 47(22):5567-78. PubMed ID: 15481992 [TBL] [Abstract][Full Text] [Related]
2. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation. Stevens M; Balzarini J; Tabarrini O; Andrei G; Snoeck R; Cecchetti V; Fravolini A; De Clercq E; Pannecouque C J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861 [TBL] [Abstract][Full Text] [Related]
3. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives. Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103 [TBL] [Abstract][Full Text] [Related]
4. A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication. Massari S; Daelemans D; Barreca ML; Knezevich A; Sabatini S; Cecchetti V; Marcello A; Pannecouque C; Tabarrini O J Med Chem; 2010 Jan; 53(2):641-8. PubMed ID: 19958026 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group. Haraguchi K; Shimada H; Tanaka H; Hamasaki T; Baba M; Gullen EA; Dutschman GE; Cheng YC J Med Chem; 2008 Mar; 51(6):1885-93. PubMed ID: 18311897 [TBL] [Abstract][Full Text] [Related]
6. Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity. Tabarrini O; Massari S; Sancineto L; Daelemans D; Sabatini S; Manfroni G; Cecchetti V; Pannecouque C ChemMedChem; 2011 Jul; 6(7):1249-57. PubMed ID: 21567967 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors. Chen S; Chen R; He M; Pang R; Tan Z; Yang M Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound. Tomassi C; Nguyen VN; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Soriano E; Postel D Bioorg Med Chem Lett; 2008 Apr; 18(7):2277-81. PubMed ID: 18353641 [TBL] [Abstract][Full Text] [Related]
9. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. Sun IC; Wang HK; Kashiwada Y; Shen JK; Cosentino LM; Chen CH; Yang LM; Lee KH J Med Chem; 1998 Nov; 41(23):4648-57. PubMed ID: 9804704 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents. Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793 [TBL] [Abstract][Full Text] [Related]
11. New anti-human immunodeficiency virus type 1 6-aminoquinolones: mechanism of action. Parolin C; Gatto B; Del Vecchio C; Pecere T; Tramontano E; Cecchetti V; Fravolini A; Masiero S; Palumbo M; Palù G Antimicrob Agents Chemother; 2003 Mar; 47(3):889-96. PubMed ID: 12604517 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives. Baba M; Okamoto M; Kawamura M; Makino M; Higashida T; Takashi T; Kimura Y; Ikeuchi T; Tetsuka T; Okamoto T Mol Pharmacol; 1998 Jun; 53(6):1097-103. PubMed ID: 9614214 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. Tabarrini O; Massari S; Daelemans D; Stevens M; Manfroni G; Sabatini S; Balzarini J; Cecchetti V; Pannecouque C; Fravolini A J Med Chem; 2008 Sep; 51(17):5454-8. PubMed ID: 18710207 [TBL] [Abstract][Full Text] [Related]
14. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission. Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines. Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290 [TBL] [Abstract][Full Text] [Related]
16. 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation. Zhan P; Liu X; Fang Z; Pannecouque C; De Clercq E Bioorg Med Chem; 2009 Sep; 17(17):6374-9. PubMed ID: 19647440 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents. Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784 [TBL] [Abstract][Full Text] [Related]
18. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues. Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV-1 activity of new MKC-442 analogues with an alkynyl-substituted 6-benzyl group. Aly YL; Pedersen EB; La Colla P; Loddo R Arch Pharm (Weinheim); 2007 May; 340(5):225-35. PubMed ID: 17464964 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams. Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]